Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Revenue: 2011-2024

Historic Revenue for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $348.9 million.

  • Mimedx Group's Revenue rose 35.30% to $113.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.4 million, marking a year-over-year increase of 14.77%. This contributed to the annual value of $348.9 million for FY2024, which is 8.52% up from last year.
  • Latest data reveals that Mimedx Group reported Revenue of $348.9 million as of FY2024, which was up 8.52% from $321.5 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Revenue registered a high of $348.9 million during FY2024, and its lowest value of $242.0 million during FY2021.
  • For the 3-year period, Mimedx Group's Revenue averaged around $312.7 million, with its median value being $321.5 million (2023).
  • As far as peak fluctuations go, Mimedx Group's Revenue declined by 17.05% in 2020, and later increased by 20.03% in 2023.
  • Over the past 5 years, Mimedx Group's Revenue (Yearly) stood at $248.2 million in 2020, then fell by 2.50% to $242.0 million in 2021, then grew by 10.67% to $267.8 million in 2022, then increased by 20.03% to $321.5 million in 2023, then increased by 8.52% to $348.9 million in 2024.